(firstQuint)Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV).

 The study will be conducted in a single centre and will consist of a single dose part and a multiple dose part.

 Seven single doses of CHF 6001 will be administered according to an escalation, alternate cross over scheme.

 Five multiple doses of CHF 6001 will be administered for 7 days according to a sequential escalation scheme.

.

 Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)@highlight

This study is designed to investigate the safety, tolerability and pharmacokinetics of inhaled CHF 6001 after single and multiple doses in healthy volunteers.

